Alliance Ends Testing on Its LiquiVent Product

Webb, Marion
May 2001
San Diego Business Journal;5/28/2001, Vol. 22 Issue 22, p9
Reports failure in the clinical trials for the drug LiquiVent of Alliance Pharmaceuticals Corp. in San Diego, California. Use of the drug in treating acute respiratory distress syndrome breath; Decision of the company to pursue the development of the drug; Impact of the failed clinical trials on the market share of Alliance.


Related Articles

  • IN THE PIPELINE.  // Drug Utilization Review;Feb2001, Vol. 17 Issue 2, p16 

    Presents updates on clinical trials in the United States (U.S.). Details on the clinical trials initiated by AeroGen Inc. for its insulin inhaler; Completion of Alliance Pharmaceutical Corporation's clinical trial on its intrapulmonary agent perflubron; Result of the clinical trial conducted by...

  • AFO 150: Imagent, Imavist.  // Drugs in R&D;2002, Vol. 3 Issue 2, p116 

    Adis Comments AFO 150 [Imavistâ„¢] consists of perfluorochemical-based microbubbles and is being developed by Alliance Pharmaceutical Corporation in the USA. AFO 150 is an ultrasound contrast agent with use in cardiac function and perfusion, and as an enhancer of the images of prostate,...

  • Research Update.  // PharmaWatch: Biotechnology;Feb2005, Vol. 4 Issue 2, p4 

    The article offers global news briefs. GloxoSmithKline has conducted phase II clinical trial of an anti-cancer drug to determine its safety in treating patients with advanced ovarian cancer. Vertex Pharmaceuticals Inc. has increased its market share after facilitating a phase 1 clinical study...

  • Results Update.  // PharmaWatch: Biotechnology;Feb2005, Vol. 4 Issue 2, p6 

    The article offers news briefs related to the biotechnology industry. An anticancer vaccine from Therion Biologics' Corp. has displayed anti-tumor activity during its phase I clinical trial. the shares of Dendreon Corp. has declined by twenty-seven percent after it disclosed its prostate cancer...

  • Oversight and Enforcement in Clinical Trials. Wechsler, Jill // Applied Clinical Trials;Sep2000, Vol. 9 Issue 9, p19 

    Reports government inspection and regulation of clinical trial studies in the United States. Selection of clinical sites; Impact of the regulation on the relationship between research oversight and drug development; Recommendations for site inspection; Negligence in reporting clinical trial...

  • New User Fee Program Aims to Spur Drug Development. Wechsler, Jill // Applied Clinical Trials;Aug2002, Vol. 11 Issue 8, p18 

    Reports on the revised user fee program signed into law by U.S. President George W. Bush to encourage clinical trials for drug development. Enhancement of ability of public health agencies to respond to bioterrorist threats; Total approval time for new drug applications; Review of...

  • Business News.  // Applied Clinical Trials;Aug2002, Vol. 11 Issue 8, p56 

    Presents news items on clinical trials for drug development as of August 2002. Budapest-based Hungarian Regulatory Affairs Society's membership in Leefdaal, Belgium-based Pan European Federation of Regulatory Affairs Societies; Entry of Port Jefferson, New York-based Symbio LLC into...

  • Clinical trials a vital part of developing new drugs. McCulley // New Orleans CityBusiness (1994 to 2008);10/04/99, Vol. 20 Issue 15, p32 

    Discusses the role of clinical trials in the development of new drugs. Work by Doctor Edward Hyman on the treatment of Gulf War Syndrome; Process of clinical trials according to cancer researcher Doctor Thomas Cosgriff; Regulation by the Food and Drug Administration.

  • CLINICAL TRIALS FOR KIDS.  // Applied Clinical Trials;May2010, Vol. 19 Issue 5, p20 

    The article reports on the drug development for children wherein clinical trials will be conducted for both children and parent particularly in the areas of genetic diseases including cystic fibrosis, influenza and head lice.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics